// App-Quantinova.ai

OP15.06 : Performance of RMI, IOTA ADNEX and simple rules risk model in the assessment of adnexal masses not classifiable using the revised benign easy descriptors as first step: a novel two‐step strategy

Researchers

Presenter

  • C. Landolfo

Principal Investigators

  • T. Bourne

  • B. De Cock

  • A.C. Testa

  • P. Sladkevicius

  • D. Fischerov

  • C. Van Holsbeke

  • D. Franchi

  • L. Savelli

  • E. Epstein

  • A. Czekierdowski

  • S. Guerriero

  • R. Fruscio

  • F. Leone

  • I. Vergote

  • J.Y. Verbakel

  • L. Valentin

  • B. Van Calster

  • D. Timmerman

Medical Centers

  • Urology, Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium

  • Department of Obstetrics and Gynecology, University Hospital Leuven, Kuleuven, Belgium

  • Department of Radiation Oncology, Catholic University of the Sacred Heart, Rome, Italy

  • Department of Obstetrics and Gynecology, Skåne University Hospital Malmö, Lund University, Malmö, Sweden

  • Department of Obstetrics and Gynecology, Gynecological Oncology Centre, Charles University, Prague, Czech Republic

  • Department of Obstetrics and Gynecology, Ziekenhuis Oost‐Limburg, Genk, Belgium

  • European Institute of Oncology, Milan, Italy

  • Obstetrics and Gynecology, Sant' Orsola‐Malpighi Hospital, University of Bologna, Bologna, Italy

  • Department of Clinical Science and Education, Södersjukhuset and Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden

  • First Department of Gynecological Oncology, Medical University of Lublin, Lublin, Poland

  • Department of Obstetrics and Gynecology, University of Cagliari, Cagliari, Italy

  • Clinic of Obstetrics and Gynecology, University of Milan‐Bicocca, San Gerardo Hospital, Monza, Italy

  • Department of Obstetrics and Gynecology, Clinical Sciences Institute Luigi Sacco, Milan, Italy

  • Department of Oncology, KU Leuven, Leuven Cancer Institute, Leuven, Belgium

  • Nuffield Department of Surgical Sciences, University of Oxford, Oxford, United Kingdom

Locations

  • Belgium

  • United Kingdom

  • Italy

  • Sweden

  • Czech Republic

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Carbohydrate antigen 125

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

  • Multicenteric

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved